Document is current
Any future updates will be listed below
-
Authors
Hunt, Timothy
Oser, Carrie B.
Friedmann, Peter D.
Mack, Nicole
Balvanz, Peter
Freisthler, Bridget
Chandler, Redonna K
Hochstatter, Karli
Harris, Daniel R.
Glasgow, LaShawn
D’Costa, Lauren
Russo, Mary R.
Eggleston, Barry
Aldridge, Arnie
Bellair, Paul
Cogan, Allyson G.
David, James L.
El-Bassel, Nabila
Goddard-Eckrich, Dawn
Gomori, Steve
Hagan, Holly
Hanson, Steve
Holloway, JaNae
Kinnard, Elizabeth N.
Knott, Charlie
Konstan, Michael W.
Walsh, Sharon L.
LeBaron, Patricia A.
Lyons, Michael S.
McGladrey, Margaret
Papp, Joan
Murphy, Sean M.
Springer, Sandra
Oga, Emmanuel
Staton, Michele
Schady, Elizabeth
Montero, Fernando
Surratt, Hilary L.
Stevens-Watkins, Danelle
Winhusen, John
Zarkin, Gary A.
Hamilton, Greer A.
Sprunger, Joel G.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (UM1 DA049415, UM1 DA049406, UM1 DA049412, UM1DA049394, UM1 DA049412, UM1DA049417, UM1 DA049415, UM1 DA049406, UM1DA049394, UM1DA049394, UM1 DA049415, UM1DA049394, UM1DA049394, UM1DA049417, UM1 DA049412, UM1 DA049415, UM1 DA049415, UM1 DA049415, UM1DA049394, UM1 DA049415, UM1DA049394, UM1 DA049412, UM1DA049394, UM1DA049417, UM1 DA049406, UM1DA049394, UM1DA049417, UM1 DA049406, UM1DA049417, UM1 DA049415, UM1DA049394, UM1 DA049406, UM1 DA049415, UM1 DA049415, UM1 DA049406, UM1 DA049406, UM1DA049417, UM1DA049394, UM1 DA049412, UM1DA049417)
- License Information
-
More Information
Article History
Received: 24 December 2024
Accepted: 30 June 2025
First Online: 25 July 2025
Declarations
:
: This study protocol (Pro00038088) was approved by Advarra Inc., the HEALing Communities Study Single Institutional Review Board. Consent to participate was not required by the Advarra IRB for this project because it is an analysis of implementation at the community and agency level rather than at the individual human participant level.
: Not applicable.
: Author Dr. Sandra Springer has provided paid scientific consultation to Alkermes Inc and has received in-kind study drug donations from Alkermes Inc and Indivior Pharmaceutical Company for NIH-funded research.
